Markovič Rene, Grubelnik Vladimir, Vošner Helena Blažun, Kokol Peter, Završnik Matej, Janša Karmen, Zupet Marjeta, Završnik Jernej, Marhl Marko
Faculty of Natural Sciences and Mathematics, University of Maribor, 2000 Maribor, Slovenia.
Faculty of Electrical Engineering and Computer Science, University of Maribor, 2000 Maribor, Slovenia.
J Pers Med. 2022 Feb 14;12(2):280. doi: 10.3390/jpm12020280.
The pathogenesis of type 2 diabetes mellitus is complex and still unclear in some details. The main feature of diabetes mellitus is high serum glucose, and the question arises of whether there are other statistically observable dysregulations in laboratory measurements before the state of hyperglycemia becomes severe. In the present study, we aim to examine glucose and lipid profiles in the context of age, sex, medication use, and mortality.
We conducted an observational study by analyzing laboratory data from 506,083 anonymized laboratory tests from 63,606 different patients performed by a regional laboratory in Slovenia between 2008 and 2019. Laboratory data-based results were evaluated in the context of medication use and mortality. The medication use database contains anonymized records of 1,632,441 patients from 2013 to 2018, and mortality data were obtained for the entire Slovenian population.
We show that the highest percentage of the population with elevated glucose levels occurs approximately 20 years later than the highest percentage with lipid dysregulation. Remarkably, two distinct inflection points were observed in these laboratory results. The first inflection point occurs at ages 55 to 59 years, corresponding to the greatest increase in medication use, and the second coincides with the sharp increase in mortality at ages 75 to 79 years.
Our results suggest that medications and mortality are important factors affecting population statistics and must be considered when studying metabolic disorders such as dyslipidemia and hyperglycemia using laboratory data.
2型糖尿病的发病机制复杂,某些细节仍不清楚。糖尿病的主要特征是血糖升高,那么在高血糖状态变得严重之前,实验室检测中是否存在其他可通过统计学观察到的失调情况就成了问题。在本研究中,我们旨在结合年龄、性别、用药情况和死亡率来研究血糖和血脂情况。
我们通过分析斯洛文尼亚一个地区实验室在2008年至2019年间对63606名不同患者进行的506083次匿名实验室检测的实验室数据,开展了一项观察性研究。基于实验室数据的结果在用药情况和死亡率的背景下进行评估。用药情况数据库包含了2013年至2018年1632441名患者的匿名记录,死亡率数据则来自整个斯洛文尼亚人口。
我们发现,血糖水平升高的人群比例最高出现的时间比血脂失调人群比例最高出现的时间晚约20年。值得注意的是,在这些实验室结果中观察到了两个明显的转折点。第一个转折点出现在55至59岁,这与用药量的最大增幅相对应,第二个转折点则与75至79岁死亡率的急剧上升相吻合。
我们的结果表明,用药情况和死亡率是影响人口统计的重要因素,在利用实验室数据研究血脂异常和高血糖等代谢紊乱时必须予以考虑。